4SC presents summary of biomarker and patient subgroup analysis of prognostic factors for survival in advanced HCC
. - Baseline and biomarker characteristics of advanced HCC patients identified that have an impact on overall survival…
. - Baseline and biomarker characteristics of advanced HCC patients identified that have an impact on overall survival…
. - Identification and further characterization of novel potentially predictive biomarker ZFP64 indicative for survival…
. - Data from completed Phase I part of SHORE study in advanced colorectal cancer (CRC) to be presented at upcoming ASC…
. - Overall survival (OS) data from Phase II SHELTER trial in advanced liver cancer (HCC) to be presented at 2012 ILCA…
4SC AG (Frankfurt, Prime Standard: VSC), a biopharmaceutical company dedicated to the discovery and development of targe…